Index RUT
P/E -
EPS (ttm) -0.51
Insider Own 19.16%
Shs Outstand 116.86M
Perf Week -4.07%
Market Cap 524.74M
Forward P/E -
EPS next Y -0.38
Insider Trans 2.25%
Shs Float 94.69M
Perf Month -16.88%
Income -50.62M
PEG -
EPS next Q -0.16
Inst Own 59.17%
Short Float 5.81%
Perf Quarter -27.63%
Sales 34.16M
P/S 15.36
EPS this Y -14.95%
Inst Trans 0.72%
Short Ratio 11.35
Perf Half Y -1.10%
Book/sh 2.69
P/B 1.66
EPS next Y 35.67%
ROA -12.03%
Short Interest 5.51M
Perf Year 28.00%
Cash/sh 0.74
P/C 6.03
EPS next 5Y -
ROE -15.43%
52W Range 3.14 - 6.72
Perf YTD -27.39%
Dividend Est. -
P/FCF 749.63
EPS past 5Y -
ROI -15.04%
52W High -33.28%
Beta -0.05
Dividend TTM -
Quick Ratio 4.11
Sales past 5Y 13.92%
Gross Margin 44.37%
52W Low 42.68%
ATR (14) 0.19
Dividend Ex-Date -
Current Ratio 4.11
EPS Y/Y TTM -121.77%
Oper. Margin -202.63%
RSI (14) 30.00
Volatility 2.76% 3.22%
Employees 106
Debt/Eq 0.08
Sales Y/Y TTM -3.34%
Profit Margin -148.16%
Recom 1.00
Target Price 10.00
Option/Short Yes / Yes
LT Debt/Eq 0.07
EPS Q/Q -292.72%
Payout -
Rel Volume 1.23
Prev Close 4.43
Sales Surprise -35.38%
EPS Surprise 1.75%
Sales Q/Q -86.36%
Earnings May 09 AMC
Avg Volume 485.11K
Price 4.48
SMA20 -10.81%
SMA50 -15.79%
SMA200 -15.80%
Trades
Volume 598,741
Change 1.13%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-29-23 Initiated
RBC Capital Mkts
Outperform
$6
Apr-21-23 Initiated
The Benchmark Company
Buy
$8
Apr-13-23 Initiated
Craig Hallum
Buy
$10
Feb-22-23 Initiated
Cowen
Outperform
$10
Feb-13-23 Initiated
H.C. Wainwright
Buy
$11
Dec-20-22 Initiated
Truist
Buy
$10
Dec-16-22 Initiated
Credit Suisse
Outperform
$13
Nov-29-22 Initiated
SVB Leerink
Outperform
$6
Nov-28-22 Initiated
Stifel
Buy
$12
Apr-22-24 08:00AM
Mar-21-24 11:31AM
Mar-20-24 08:54PM
04:05PM
Feb-28-24 08:27AM
08:00AM
Loading…
Feb-26-24 08:00AM
Feb-20-24 08:00AM
Dec-14-23 04:30PM
Nov-20-23 12:39PM
Nov-14-23 05:03AM
Nov-09-23 05:55PM
09:24AM
08:00AM
Nov-02-23 08:00AM
Nov-01-23 09:00AM
04:28PM
Loading…
Oct-31-23 04:28PM
Oct-26-23 02:32PM
Oct-12-23 08:00AM
Sep-05-23 08:00AM
Aug-15-23 05:20AM
Aug-13-23 08:06AM
Aug-10-23 04:05PM
Aug-07-23 04:05PM
Jul-31-23 08:00AM
Jul-17-23 07:35AM
Jun-13-23 06:00AM
May-18-23 05:09PM
May-17-23 04:05PM
May-16-23 06:06AM
May-14-23 08:03AM
10:55PM
Loading…
May-11-23 10:55PM
(Thomson Reuters StreetEvents)
07:00AM
May-05-23 07:14AM
May-04-23 06:26AM
May-01-23 08:00AM
Apr-26-23 08:01PM
Apr-25-23 08:00AM
Apr-19-23 08:30AM
Apr-07-23 10:24PM
Apr-05-23 06:09AM
Apr-02-23 08:51AM
Mar-31-23 08:40AM
Mar-30-23 04:05PM
Mar-15-23 11:44AM
Mar-09-23 08:00AM
Mar-08-23 09:53AM
Feb-23-23 07:49AM
Feb-07-23 08:00AM
Feb-01-23 06:56AM
Dec-16-22 12:39PM
Dec-01-22 08:47AM
Nov-15-22 07:00AM
Nov-03-22 08:00AM
Nov-02-22 07:00AM
Nov-01-22 04:01PM
04:01PM
OmniAb, Inc. operates as a drug discovery company. It focuses on developing human monoclonal and bispecific therapeutic antibodies. Its platform includes the biological intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse. The company was founded on December 14, 2015 and is headquartered in Emeryville, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
GUSTAFSON KURT A Executive VP, Finance and CFO Apr 08 '24 Sale 5.27 6,954 36,648 176,697 Apr 09 06:38 PM Berkman Charles S Chief Legal Officer Apr 08 '24 Sale 5.27 6,954 36,648 292,617 Apr 09 06:37 PM GUSTAFSON KURT A Executive VP, Finance & CFO Apr 01 '24 Sale 5.46 11,849 64,696 170,110 Apr 02 06:30 PM FOEHR MATTHEW W President and CEO Mar 27 '24 Option Exercise 3.72 243,613 907,023 3,152,416 Mar 29 04:52 PM FOEHR MATTHEW W President and CEO Mar 22 '24 Buy 5.19 225,000 1,167,750 2,908,803 Mar 25 07:07 AM FOEHR MATTHEW W Chief Executive Officer Dec 12 '23 Buy 5.05 200,000 1,010,000 2,645,442 Dec 13 03:25 PM FOEHR MATTHEW W President and CEO Nov 10 '23 Buy 4.27 95,000 405,517 2,427,919 Nov 13 08:00 AM FOEHR MATTHEW W President and CEO Aug 14 '23 Buy 5.48 45,000 246,600 2,332,919 Aug 15 04:56 PM FOEHR MATTHEW W Chief Executive Officer Jun 09 '23 Buy 4.52 115,000 519,800 2,574,009 Jun 12 04:47 PM HIGGINS JOHN L Director May 23 '23 Option Exercise 3.68 9,000 33,120 2,471,686 May 25 04:45 PM HIGGINS JOHN L Director May 23 '23 Sale 4.05 9,000 36,450 2,462,686 May 25 04:45 PM HIGGINS JOHN L Director May 19 '23 Option Exercise 3.68 1,000 3,680 2,463,686 May 23 04:12 PM HIGGINS JOHN L Director May 19 '23 Sale 4.05 1,000 4,050 2,462,686 May 23 04:12 PM HIGGINS JOHN L Director May 18 '23 Option Exercise 3.68 50,000 184,000 2,512,686 May 19 05:03 PM HIGGINS JOHN L Director May 18 '23 Sale 3.89 50,000 194,500 2,462,686 May 19 05:03 PM FOEHR MATTHEW W Chief Executive Officer May 12 '23 Buy 3.40 440,000 1,496,000 2,438,414 May 15 04:02 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite